Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...

What’s old was “new” again at the 130th grand masked ball of the Krewe of Nereus, which commemorated the 125th anniversary of the world’s first electric parade: the krewe’s! History ...

The U.S. and its major trading partners have agreed to reciprocal tariff elimination for pharmaceutical products and chemicals used in drug production for the past 30 years, according to the U.S ...

Amgen is one of many global pharmaceutical players looking to expand their presence in India, the so-called "pharmacy of the world". India and the U.S. agreed this month to start talks to clinch ...

Novo Nordisk will outlay $6.5bn in 2025 to ramp up production in the US. Image credit: Shutterstock / KK Stock. Compounders are on alert after the US Food and Drug Administration (FDA) declared the ...

A look at the shareholders of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 57% ownership.

India's CRDMO industry is projected to grow from USD 7 billion to USD 14 billion by 2028, driven by pharmaceutical outsourcing and regulatory support. The industry's growth could reach a high-teens ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...